651
Participants
Start Date
September 30, 2020
Primary Completion Date
July 18, 2024
Study Completion Date
July 18, 2024
mRNA-1345
Formulation for injection
Placebo
0.9% sodium chloride (normal saline) injection
Velocity Clinical Research - Columbia - PPDS, Columbia
Michael W. Simon, M.D., PSC, Nicholasville
Henry Ford Health System, Detroit
Synexus - Optimal Research - Peoria, Peoria
Velocity Clinical Research (Omaha - Nebraska) - PPDS, Omaha
Velocity Clinical Research (Norfolk - Nebraska) - PPDS, Norfolk
Velocity Clinical Research (Grand Island - Nebraska) - PPDS, Grand Island
Velocity Clinical Research (Hastings - Nebraska) - PPDS, Hastings
Velocity Clinical Research (Metaire - Louisiana) - PPDS, Metairie
Cyfair Clinical Research Center - ERN - PPDS, Houston
Tanner Clinic, Layton
Mills Clinical Research, West Hollywood
Paradigm Clinical Research Institute Inc - ClinEdge - PPDS, La Mesa
Accel Research Site - Angel Kids Pediatrics - ERN - PPDS, DeLand
Accel Research Sites - Nona Pediatric Center - ERN - PPDS, Orlando
Palm Beach Research - ClinEdge - PPDS, West Palm Beach
Centricity Research - Roswell - HyperCore - PPDS, Columbus
IResearch Atlanta LLC, Decatur
Velocity Clinical Research (Savannah - Georgia) - PPDS, Savannah
East-West Medical Research Institute, Honolulu
Velocity Clinical Research (Sioux City - Iowa) - PPDS, Sioux City
Velocity Clinical Research (Lafayette - Louisiana) - PPDS, Lafayette
Velocity Clinical Research (Slidell - Louisiana) - PPDS, Slidell
Alliance for Multispecialty Research - Kansas City, Kansas City
Velocity Clinical Research (Albuquerque - New Mexico) - PPDS, Albuquerque
Velocity Clinical Research (Binghamton - New York) - PPDS, Binghamton
Velocity Clinical Research - Medford - ERN - PPDS, Medford
Velocity Clinical Research (Greenville - South Carolina) - PPDS, Greenville
Flourish Research - San Antonio - PPDS, San Antonio
DM Clinical Research, Tomball
Clinical Research Partners LLC, Richmond
ModernaTX, Inc.
INDUSTRY